Following up on a Q on the recommended length for a biopharma pitch deck, here are a few thoughts on how to make your deck “typical” for decks put out by experienced teams. You want to avoid any “tells” that investors associate with a less experienced, less clued-in teams.
- Don’t send a Word teaser – biopharma VCs are... See more
Sara Nayeemx.com